Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 USD | -16.67% | -19.03% | -23.40% |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 1.736 | 0.8898 | 0.9277 | 1.557 | 0.9384 | 1.854 |
Enterprise Value (EV) 1 | 1.048 | 0.7 | 2.143 | 1.678 | 1.55 | 1.854 |
P/E ratio | 3.6 x | -2.95 x | -1.32 x | -15.1 x | -28 x | 8.37 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.15 x | 0.09 x | 0.1 x | 0.15 x | 0.09 x | 0.15 x |
EV / Revenue | 0.09 x | 0.07 x | 0.23 x | 0.16 x | 0.14 x | 0.15 x |
EV / EBITDA | 4.13 x | -3.45 x | -2.88 x | 151 x | -3.68 x | 3.54 x |
EV / FCF | 3.17 x | -1.96 x | -32.4 x | 2.06 x | -1.87 x | 12 x |
FCF Yield | 31.5% | -51.1% | -3.09% | 48.6% | -53.4% | 8.36% |
Price to Book | 0.96 x | 0.59 x | 1.07 x | 1.91 x | 1.13 x | 1.44 x |
Nbr of stocks (in thousands) | 7,551 | 7,415 | 7,415 | 7,415 | 7,415 | 7,415 |
Reference price 2 | 0.2299 | 0.1200 | 0.1251 | 0.2100 | 0.1266 | 0.2500 |
Announcement Date | 9/28/18 | 9/27/19 | 9/28/20 | 9/27/21 | 9/28/22 | 10/13/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 11.4 | 9.627 | 9.4 | 10.47 | 10.7 | 12.18 |
EBITDA 1 | 0.2539 | -0.2028 | -0.7446 | 0.0111 | -0.4216 | 0.5237 |
EBIT 1 | 0.2047 | -0.253 | -0.7947 | -0.0337 | -0.4701 | 0.4785 |
Operating Margin | 1.8% | -2.63% | -8.45% | -0.32% | -4.39% | 3.93% |
Earnings before Tax (EBT) 1 | 0.5837 | -0.25 | -0.6503 | -0.052 | 0.0181 | 0.4568 |
Net income 1 | 0.5837 | -0.25 | -0.6503 | -0.052 | 0.0181 | 0.4568 |
Net margin | 5.12% | -2.6% | -6.92% | -0.5% | 0.17% | 3.75% |
EPS 2 | 0.0638 | -0.0407 | -0.0947 | -0.0140 | -0.004520 | 0.0299 |
Free Cash Flow 1 | 0.3305 | -0.3575 | -0.0662 | 0.8162 | -0.8278 | 0.155 |
FCF margin | 2.9% | -3.71% | -0.7% | 7.79% | -7.73% | 1.27% |
FCF Conversion (EBITDA) | 130.14% | - | - | 7,343.39% | - | 29.59% |
FCF Conversion (Net income) | 56.62% | - | - | - | - | 33.92% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/28/18 | 9/27/19 | 9/28/20 | 9/27/21 | 9/28/22 | 10/13/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 1.22 | 0.12 | 0.61 | 0 |
Net Cash position 1 | 0.69 | 0.19 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | -1.633 x | 10.91 x | -1.45 x | 0.000391 x |
Free Cash Flow 1 | 0.33 | -0.36 | -0.07 | 0.82 | -0.83 | 0.15 |
ROE (net income / shareholders' equity) | 32.5% | -10.9% | -35.4% | -3.5% | 1.23% | 26.8% |
ROA (Net income/ Total Assets) | 2.46% | -3% | -9.16% | -0.37% | -5.41% | 5.71% |
Assets 1 | 23.75 | 8.346 | 7.103 | 14.09 | -0.334 | 8.004 |
Book Value Per Share 2 | 0.2400 | 0.2000 | 0.1200 | 0.1100 | 0.1100 | 0.1700 |
Cash Flow per Share 2 | 0.1200 | 0.0600 | 0.1100 | 0.2200 | 0.0800 | 0.1200 |
Capex 1 | 0.03 | 0.02 | 0.06 | 0.01 | - | 0.01 |
Capex / Sales | 0.26% | 0.23% | 0.64% | 0.09% | - | 0.05% |
Announcement Date | 9/28/18 | 9/27/19 | 9/28/20 | 9/27/21 | 9/28/22 | 10/13/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-23.40% | 1.48M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- ESMC Stock
- Financials Escalon Medical Corp.